University of Dundee

Latest News for 05/2022

March 2016

  • 08 Mar 2016

    World-leading medicinal chemistry and biology at the Universities of Dundee (Scotland) and Cape Town (South Africa) have been allied to the industrial expertise of the Pharmaceuticals Division of Bayer (Germany), one of the world’s leading pharma companies, in an effort to develop critically needed new treatments for tuberculosis (TB).   The collaboration combines some of the world’s best knowledge on TB biology, drug discovery and medicinal chemistry, with access to an industrial library of chemical compounds.  

February 2015

  • 05 Feb 2015

    The University of Dundee has entered into a Research Program Agreement with Pfizer Inc. to jointly conduct research that may lead to potential novel treatments for Cystic Fibrosis.   The project will be carried out as part of Pfizer’s Rare Disease Consortium and builds on a program of research within the laboratory of Professor Irwin McLean, Head of Molecular Medicine at Dundee, and the University’s Drug Discovery Unit.  

March 2013

February 2013

April 2012

October 2011

April 2010

  • 01 Apr 2010

    Scientists from the Drug Discovery Unit (DDU) at the University of Dundee – working together with partners at the University of York and the Structural Genomics Consortium - have made a major breakthrough in identifying new treatments for a fatal disease which infects tens of thousands of Africans each year.

Pages